Conversely, the low expression of plectin is considered an indicator of poorer overall survival in sarcoma, thymoma, pheochromocytoma, and paraganglioma, suggesting that the role of plectin in cancer may depend on tissue- or context-specific factors [15]. Here, PLEC is linked to pheochromocytoma.